Applied Biocode Corporation (6598) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Applied Biocode Corporation (6598:TWSE), powered by AI.

Current Price
$24.40
Sector
Healthcare
What is the Applied Biocode Corporation stock price forecast?

Applied Biocode Corporation is currently trading at $24.40. View real-time AI analysis on Alpha Lenz.

What is Applied Biocode Corporation insider trading activity?

View the latest insider trading data for Applied Biocode Corporation on Alpha Lenz.

What is Applied Biocode Corporation's P/E ratio?

View Applied Biocode Corporation's valuation metrics on Alpha Lenz.

Applied Biocode Corporation

TWSE · 6598
NT$24.40+0.00(+0.00%)
Ask about Applied Biocode Corporation's future dividend policy...
Alpha Chat Insight

Applied Biocode Corporation's ROE is -26.4%. Explore profitability and growth together.

Ask for details

Company Overview

Applied Biocode Corporation is a biotechnology company that specializes in developing and manufacturing multiplex molecular diagnostic products. These products are primarily used to identify and analyze genetic material from various biological samples. The company’s main offerings include a range of molecular diagnostic solutions that enable simultaneous testing of multiple pathogens or genetic markers, significantly enhancing efficiency and reducing costs in clinical laboratories. Applied Biocode's technology is widely applicable across several sectors, including healthcare, where its products assist in diagnosing infectious diseases, genetic predispositions, and other medical conditions. The company’s work not only aids hospitals and clinics but also supports research and public health initiatives by providing essential data for monitoring disease outbreaks and trends. In the financial market, Applied Biocode Corporation holds a crucial role as an innovator in the biotech industry, contributing to advancements in medical diagnostics and biotechnology research. Its products are critical for improving the speed and accuracy of laboratory testing, thus playing a vital part in the global effort to enhance healthcare outcomes. As biotechnology continues to evolve, Applied Biocode remains at the forefront, influencing industry standards and practices with its cutting-edge solutions.

CEODr. Winston Z. Ho Ph.D.
SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$475.20MRevenue
0.00Shares Out
0Employees

Margins

54.90%Gross
-30.02%EBITDA
-46.89%Operating
-42.32%Pre-Tax
-42.34%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.78%Rev 3Yr
9.71%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-18.06%ROA
-26.44%ROE
-17.91%ROIC

Financial Health

NT$464.79MCash & Cash Equivalents
NT$-95.30MNet Debt
57.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Applied Biocode Corporation (ticker: 6598) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 24.4 with a P/E ratio of -x and P/B of -x.

ROE is -26.44% and operating margin is -46.89%. Annual revenue is $475M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Applied Biocode Corporation (6598) Stock Forecast 2026 $24.40 — Price, Financials & Analyst Targets | Alpha Lenz